2705, boulevard Laurier
R0-709
Québec, Québec
Canada G1V 4G2
Dernières nouvelles
Impact of Hepatitis C Virus Cure on Depressive Symptoms in the Human Immunodeficiency Virus-Hepatitis C Virus Coinfected Population in Canada
Article de revueClin Infect Dis, 76 (3), 2023.
Predicting the presence of depressive symptoms in the HIV-HCV co-infected population in Canada using supervised machine learning
Article de revueBMC Med Res Methodol, 22 (1), 2022.
An adaptable platform for in-house hepatitis C serology
Article de revueJ Virol Methods, 308 , 2022.
Direct-acting antiviral treatment uptake and sustained virological response outcomes are not affected by alcohol use: A CANUHC analysis
Article de revueCan Liver J, 4 (3), 2021.
Salvage Therapy with Sofosbuvir/Velpatasvir/Voxilaprevir in DAA-experienced Patients: Results from a Prospective Canadian Registry
Article de revueClin Infect Dis, 72 (11), 2021.
To Induce Immune Reconstitution Inflammatory Syndrome or Suppress It: The Spectrum of Mycobacterium genavense in the Antiretroviral Era
Article de revueClin Infect Dis, 72 (2), 2021.
Hepatitis C virus infection characteristics and treatment outcomes in Canadian immigrants
Article de revueBMC Public Health, 20 (1), 2020.
Eliminating Structural Barriers: The Impact of Unrestricted Access on Hepatitis C Treatment Uptake Among People Living With Human Immunodeficiency Virus
Article de revueClin Infect Dis, 71 (2), 2020.
Real-world health care utilization in treatment of HCV: Results from the Canadian SIMPLE observational trial
Article de revueCan Liver J, 2 (3), 2019.
Molecular surveillance of hepatitis C virus genotypes identifies the emergence of a genotype 4d lineage among men in Quebec, 2001-2017
Article de revueCan Commun Dis Rep, 45 (9), 2019.
Projets actifs
- Optimiser le dépistage des populations vulnérables par goutte de sang séché, du 2022-01-15 au 2024-10-15
- Optimization of a live microneutralization assay to evaluate antibody levels against mpox in vaccinated or infected individuals in Quebec, du 2023-04-24 au 2024-04-23
Projets terminés récemment
- After the Cure: Measuring the full impacts of direct acting antivirals for people living with HIV/hepatitis C virus coinfection in Canada, du 2022-10-01 au 2023-03-31
- Surveillance des réponses immunitaires au vaccin contre la COVID-19 chez les personnes vivant avec le VIH-1, du 2021-12-01 au 2022-11-30
- The National CIHR Hepatisis C Network (NCHCN), du 2015-04-01 au 2021-10-31